Abiopharma

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

New Form S-1 - cbdMD, Inc. Filed: 2026-01-22 AccNo: 0001437749-26-001692 Size: 816 KB

Tilray Medical rafforza la propria presenza sul mercato italiano con il lancio di Tilray Medical Italia e lampliamento del proprio portafoglio di prodotti a base di cannabis terapeutica

Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique

Tilray Medical stärkt die Marktpräsenz in Italien mit der Gründung von Tilray Medical Italia und einem erweiterten Portfolio an medizinischen Cannabis-Produkten

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

RedHill Biopharma (RDHL) Files Form 6-K

New Form SCHEDULE 13G/A - Immuneering Corp Filed: 2026-01-22 AccNo: 0001790340-26-000020 Size: 7 KB

Vistagen Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Vistagen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 16, 2026 - VTGN

Class Action Filed Against Integer Holdings Corporation (ITGR) Seeking Recovery for Investors - Contact The Gross Law Firm

Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26

OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software

Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi

Jin Medical Announces the Official Commencement Date of Chuzhou Facility

PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101